Ethanol-based, stability-indicating RP-HPLC of the hydrolytically labile prodrug azilsartan medoxomil on a phenyl stationary phase: response-surface development and greenness assessment
This study presents the development and validation of a green, stability-indicating RP-HPLC method using a phenyl stationary phase and ethanol-based mobile phase for the accurate quantification of the hydrolytically labile prodrug azilsartan medoxomil in tablets, optimized via response surface methodology and assessed with multiple greenness metrics.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
High blood pressure is a silent force that strains the heart and vessels, and for millions of people, managing it relies on a class of medicines known as sartans. These drugs work by blocking a specific receptor in the body that tightens blood vessels, allowing them to relax. One of the most effective members of this family is a molecule called azilsartan medoxomil. It is designed as a "prodrug," meaning it is a slightly modified version of the active drug that the body must convert once swallowed. This modification is a delicate chemical bond, an ester, that makes the medicine soluble and ready for absorption. However, this same bond is fragile; if the molecule meets water or certain chemicals too early, it breaks apart before it can do its job. This fragility creates a significant challenge for scientists who must test the medicine to ensure it is pure and potent. They need a way to measure the intact drug without accidentally breaking it down during the test itself, all while trying to avoid using toxic chemicals that harm the environment.
In a recent study, researchers set out to solve this dual problem: how to measure this fragile drug accurately while making the testing process safer for the planet. The team, working at institutions in Ukraine, focused on replacing the standard, hazardous solvents used in liquid chromatography—a technique that separates chemicals like a sieve sorting sand from pebbles—with a greener alternative. Instead of using acetonitrile or methanol, which are derived from petroleum and carry health risks, they turned to ethanol, the alcohol found in beverages, which is renewable and far less toxic. The challenge was that ethanol behaves differently in a laboratory setting; it is thicker and moves more slowly through the testing column, which can make the separation of chemicals difficult. Furthermore, because the drug they were testing is so sensitive to water, the researchers had to ensure that the ethanol they used did not contain enough moisture to trigger the drug's breakdown during the analysis.
To tackle these issues, the scientists developed a new testing method using a specialized column coated with a phenyl material, a surface that interacts differently with the drug's unique chemical structure than the standard carbon-based columns. They treated the drug's instability not as a minor inconvenience but as the primary rule for designing the experiment. By keeping the sample solutions and the testing machine cold, they were able to slow down the chemical reaction that breaks the drug apart. They also carefully adjusted the acidity of the liquid moving through the column and the amount of ethanol mixed in, using a mathematical modeling approach to find the perfect balance where the drug stays intact but separates cleanly from its breakdown products. This process allowed them to map out exactly how the drug behaves under different conditions, ensuring that the test measures the medicine as it exists in the pill, not as a degraded version formed during the test.
The results showed that this new approach works exceptionally well. The team successfully separated the intact drug from its hydrolysis product and other potential impurities with high precision. When they tested the method on commercial tablets, the results matched the label claims perfectly, proving the technique is reliable for routine quality control. Crucially, the study confirmed that by keeping the samples at a cool five degrees Celsius and using pure ethanol, they could prevent the drug from degrading significantly during the hours it takes to run the test. This means the method measures the true amount of medicine in the bottle, rather than a mix of medicine and its broken-down parts.
Beyond the technical success, the researchers evaluated how "green" their new method truly is. They used four different scoring systems to measure the environmental impact, looking at everything from the toxicity of the chemicals to the energy used and the waste generated. The new method scored very highly, earning a rating of 88 out of 100 on one scale, which indicates an excellent environmental profile. The main reasons for this high score were the replacement of toxic solvents with ethanol and the use of a volatile buffer that does not leave behind hazardous waste. The only remaining environmental costs came from the sheer volume of liquid used and the fact that the test is done on one drug at a time, rather than multiple drugs simultaneously. However, compared to the traditional methods that rely on dangerous chemicals, this new approach represents a significant step forward. It demonstrates that it is possible to maintain the rigorous standards required for pharmaceutical safety while drastically reducing the harm to the environment and the health risks to the scientists performing the tests.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.